€1.3M funding for MastCURe's innovative mast-cell directed therapies

BASEL, Switzerland, April 17, 2026 /PRNewswire/ -- MastCURe, a high-profile research consortium, has been awarded €1.3M in funding from the Eureka Eurostars program. The collaboration comprising Allegria Therapeutics, Cube Biotech, and the Fraunhofer Institute for Translational Medicine...

Read More